The ROE as of September 2024 (TTM) for NeoGenomics, Inc. (NEO) is -8.43%

According to NeoGenomics, Inc.’s latest financial reports and current stock price. The company's current ROE is -8.43%. This represents a change of 299.30% compared to the average of -2.11% of the last 4 quarters.

NeoGenomics, Inc. (NEO) Historical ROE (quarterly & annually)

How has NEO ROE performed in the past?

The mean historical ROE of NeoGenomics, Inc. over the last ten years is -2.42%. The current -8.43% ROE has changed 247.99% with respect to the historical average. Over the past ten years (40 quarters), NEO's ROE was at its highest in in the June 2021 quarter at 6.61%. The ROE was at its lowest in in the March 2022 quarter at -4.60%.

NeoGenomics, Inc. (NEO) ROE by Quarter and Year

Discovering the peaks and valleys of NeoGenomics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeoGenomics, Inc. (NEO) Average ROE

How has NEO ROE performed in the past?

The current ROE of NeoGenomics, Inc. (NEO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

NeoGenomics, Inc. (NEO) ROE vs. Peers

How is NEO’s ROE compared to its peers?

NeoGenomics, Inc.’s ROE is greater than Natera, Inc. (-36.74%), less than Qiagen N.V. (2.00%), greater than Neogen Corporation (-0.30%), greater than Guardant Health, Inc. (-432.71%), greater than CareDx, Inc (-54.28%), greater than Myriad Genetics, Inc. (-30.89%), less than Invitae Corporation (472.72%), greater than Castle Biosciences, Inc. (-0.77%), less than Syneos Health, Inc. (2.06%), greater than Mettler-Toledo International Inc. (-554.04%), less than ICON Public Limited Company (7.68%), less than IQVIA Holdings Inc. (22.79%), less than Charles River Laboratories International, Inc. (12.11%), less than Sotera Health Company (9.59%), greater than Olink Holding AB (publ) (-7.07%), greater than Aclaris Therapeutics, Inc. (-39.83%), greater than Twist Bioscience Corporation (-38.91%), greater than Biodesix, Inc. (-525.32%),

Build a custom stock screener for NeoGenomics, Inc. (NEO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeoGenomics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeoGenomics, Inc. (NEO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeoGenomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.